186 related articles for article (PubMed ID: 6291803)
1. The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.
Levin RI; Weksler BB; Jaffe EA
Circulation; 1982 Dec; 66(6):1299-307. PubMed ID: 6291803
[TBL] [Abstract][Full Text] [Related]
2. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation.
Dickinson NT; Jang EK; Haslam RJ
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):371-7. PubMed ID: 9163326
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
4. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
Mehta J; Mehta P; Hay D
Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
[TBL] [Abstract][Full Text] [Related]
5. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
6. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells.
Levin RI; Jaffe EA; Weksler BB; Tack-Goldman K
J Clin Invest; 1981 Mar; 67(3):762-9. PubMed ID: 6782121
[TBL] [Abstract][Full Text] [Related]
8. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
10. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
Lidbury PS; Antunes E; de Nucci G; Vane JR
Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
Schafer AI; Zavoico GB; Loscalzo J; Maas AK
Blood; 1987 May; 69(5):1504-7. PubMed ID: 3032310
[TBL] [Abstract][Full Text] [Related]
12. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro.
Toivanen JL
Prostaglandins Leukot Med; 1987 Mar; 26(3):265-80. PubMed ID: 3554268
[TBL] [Abstract][Full Text] [Related]
13. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
Schafer AI; Crawford DD; Gimbrone MA
J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
[TBL] [Abstract][Full Text] [Related]
14. Influence of endothelin on human platelet aggregation and prostacyclin generation from human vascular endothelial cells in culture.
Kato K; Sawada S; Toyoda T; Kobayashi K; Shirai K; Yamamoto K; Tamagaki T; Yamagami M; Yoneda M; Takada O
Jpn Circ J; 1992 May; 56(5):422-31. PubMed ID: 1318427
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic significance of cyclic nucleotides in the environment for fetal growth--effects of PGI2-like substance on fetal platelet function].
Kihira M; Matsumoto T; Morikawa F; Ito M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):691-8. PubMed ID: 6306121
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
19. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition by endothelins of thrombin-induced aggregation and Ca2+ mobilization in human platelets.
Astarie-Dequeker C; Iouzalen L; David-Dufilho M; Devynck MA
Br J Pharmacol; 1992 Aug; 106(4):966-71. PubMed ID: 1393294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]